Zdrowie i gospodarka · 13/06/2019
FDA Extends Comment Period for Substantial Equivalence Reports
The Food and Drug Administration (FDA) is extending the comment period for a proposed rule related to substantial equivalence reports, following requests from interested parties for an additional time frame to submit comments.
Source: Federal Register — Food and Drug AdministrationOpen original release →